Source: RSC Advances. Unidade: IQSC
Subjects: QUÍMICA MÉDICA, NEOPLASIAS, PÂNCREAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUILLES JUNIOR, José Carlos et al. Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells. RSC Advances, v. 9, n. 45, p. 36699-36706, 2019Tradução . . Disponível em: https://doi.org/10.1039/c9ra07161j. Acesso em: 06 out. 2024.APA
Quilles Junior, J. C., Rocho, F. dos R., Montanari, C. A., Leitão, A., Mignone, V. W., Arruda, M. A., et al. (2019). Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells. RSC Advances, 9( 45), 36699-36706. doi:10.1039/c9ra07161jNLM
Quilles Junior JC, Rocho F dos R, Montanari CA, Leitão A, Mignone VW, Arruda MA, Turyanska L, Bradshaw TD. Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells [Internet]. RSC Advances. 2019 ; 9( 45): 36699-36706.[citado 2024 out. 06 ] Available from: https://doi.org/10.1039/c9ra07161jVancouver
Quilles Junior JC, Rocho F dos R, Montanari CA, Leitão A, Mignone VW, Arruda MA, Turyanska L, Bradshaw TD. Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells [Internet]. RSC Advances. 2019 ; 9( 45): 36699-36706.[citado 2024 out. 06 ] Available from: https://doi.org/10.1039/c9ra07161j